{
  "report_rows": [
    {
      "kpi": "Q2 subscription revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.835B vs. cons $3.817B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 cRPO CC growth",
      "prediction": "BEAT",
      "answer": "pred ~20.0% vs. cons 19.54%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 non-GAAP operating income",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.055B vs. cons $1.045B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 subscription revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.010B vs. cons $4.005B",
      "confidence": "LOW"
    },
    {
      "kpi": "Q3 cRPO CC growth",
      "prediction": "BETTER",
      "answer": "guide ~20.0% vs. cons 19.42%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 subscription revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~$15.82B vs. cons $15.761B",
      "confidence": "LOW"
    },
    {
      "kpi": "FY26 Now Assist commentary",
      "prediction": "UNKNOWN",
      "answer": "reaffirm >$1.5B ACV target; no reliable numeric consensus",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 4.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": 2.0,
  "day5_path": "STABILIZE",
  "day5_rationale": "STABILIZE \u2014 modest organic/cRPO improvement supports initial upside, but limited estimate revision prevents follow-through",
  "day5_confidence": "LOW"
}